EU Hepatitis

  

About the Program

• Program Overview
• Target Audience
• Learning Objectives
• Faculty
• Accreditation Statement
• Credit Designation
• Disclosure of Conflicts of Interest 
• Disclosure of Unlabeled Use
• Instructions for Participation and Credit
• Disclaimer
• Request for Program Slides and Review

Program Overview

This 1 hour internet symposium will review and discuss the key studies on assessing and managing Hepatitis Co-infection in HIV-positive patients. This symposium will feature an interview of Mark Sulkowski, MD, one of the leading experts on Hepatitis and Co-infection in HIV, by Calvin Cohen, MD, MS, Research Director of CRI New England and Clinical Instructor at Harvard Medical School.

This program is certified for CME credit for US physicians by the Postgraduate Institute for Medicine. This program is for health care providers who treat HIV-positive patients, there are no prerequisites.

Program Note: While there is mutual recognition of CME credits between Europe and the US, an application has been submitted to the European Union of Medical Specialists (UEMS) for approval to provide direct EACCME accredited continuing medical education for European participants.

Back to Top

 

Target Audience

This activity has been designed to meet the educational needs of physicians involved in the care of patients with HIV infection.

Back to Top

Learning Objectives

Following this program, participants will be able to:

1. Explain key clinical research evaluating ART regimens and strategies in HIV patients with hepatitis co-infection;

2. Discuss the potential effect of untreated hepatitis co-infection on the clinical course of HIV infection;

3. Describe data regarding the assessment and management of hepatitis co-infection to improve the overall health of HIV-positive patients;

4. Select HIV and hepatitis co-infection treatment regimens that maximize each patient's chance of long-term success and avoidance of HIV and hepatitis co-infection complications. 

Release Date: January 19, 2010
Expiration Date: January 19, 2011

Estimated time to complete the Hepatitis Web Symposium: 1 hour 15 minutes

Media: Internet

Back to Top

Faculty

Calvin J. Cohen, MD, MS
Research Director, CRI New England,
Clinical Instructor, Harvard Medical School
Boston, Massachusetts

Mark Sulkowski, MD
Associate Professor of Medicine and Medical Director,
Viral Hepatitis Center,
Johns Hopkins University School of Medicine
Baltimore, Maryland

Back to Top  

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and ViralEd, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.   

Back to Top

Credit Designation

Postgraduate Institute for Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1.25 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflicts of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary busniess interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or thier spouse/life partner have with commercial interests related to the content of these CME activities:

Dr. Mark Sulkowski:

• Contracted Research: Gilead; Merck; Genentech; Abbott; Tibotec; BIPI
• Consulting Fees: Gilead; Merck; Genentech; Abbott; Tibotec; BIPI

Dr. Calvin Cohen:

• Contracted Research: Bristol-Myers Squibb; Gilead; Merck & Co.; Pfizer; Tibotec
• Consulting Fees: Bristol-Myers Squibb; Gilead; Merck & Co.; Pfizer; Tibotec
• Speakers' Bureau: Bristol-Myers Squibb; Gilead; Merck & Co.; Tibotec  

The planners and managers reported the following financial relationships or relationships to products or devices they or thier spouse/life partner have with commercial interests related to the content of these CME activities:

The following PIM planners and managers: Jan Hixon, RN, BSN, MS, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN, Samantha Mattiucci, PharmD and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interest related to the content of these activities of any amount during the past 12 months.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), ViralEd, LLC, and Merck & Co., Inc. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ViralEd, LLC, and Merck & Co., Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Instructions for Participation and Credit

There are no fees for participating and receiving credit for these activities.  During the period, January 19, 2010 through January 19, 2011, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form. 

To answer the questions, click on your selected choice for each answer then proceed to the next question.  We recommend that you print a copy of your answers before you submit them to us.  Once completed, click on the Submit Post-test at the bottom of the page.  Your post-test will automatically be graded.

If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately.  Click on View Certificate and print the certificate for your records.  If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test.  You may retake the post-test until successful.

To take the post-test for the Hepatitis Web Symposium click here: Hepatitis Web Symposium CME Test

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Back to Top

Request for Program Slides and Review

To request a copy of the program slides as well as further education on how to use the slides please Click Here to fill out a content request form.

 Supported by an educational grant from Merck & Co., Inc.

---